Feasibility of a 8-week Telerehabilitation Program for Patients With Thoracic Neoplasia Receiving Chemotherapy (TELErp)
Feasibility of an Eight-week Telerehabilitation Program for Patients With Unresectable Thoracic Neoplasia Receiving Chemotherapy
Exercise-based rehabilitation improves physical function, fatigue and quality of life in patients with thoracic neoplasia. Consequently, the need for rehabilitation across the continuum of care in oncology is growing rapidly. However, the implementation of this type of intervention is limited because of many barriers such as patients' symptoms and poor accessibility to programs. In this context, healthcare systems should develop and implement new approaches to dispense these services. Consequently, telerehabilitation is a promising strategy to improve access and adherence to rehabilitation.
OBJECTIVES To investigate the feasibility, adherence and satisfaction of a home-based telerehabilitation program (TELERP) with real-time physiological parameters acquisition in patients with unresectable thoracic neoplasia receiving chemotherapy and to explore its effects on patients' functional capacity.
METHODS Five patients receiving chemotherapy followed an 8-week TELERP using real-time monitoring combined with interactive exercises. The TELERP included supervised (15) and unsupervised (9) strengthening and cardiovascular exercise sessions at a rate of 3 sessions/week. The feasibility of the TELERP, adverse outcomes, technical issues, program adherence and satisfaction were analysed. Prior to and after the program, a six-minute walking test (6MWT), a timed up and go (TUG) and a timed stair test (TST) were done to assess functional capacity
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
-
Quebec, Kanada
- CRIUCPQ
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Patients had to have an ECOG functional status of 0 (Asymptomatic) or 1 (Symptomatic but completely ambulatory);
- Have a sufficient understanding of verbal and written French instructions
- Live in a geographic region served by a high speed Internet connection.
Exclusion Criteria:
- oxygen pulsed saturation (SpO2) <80% during the cardiopulmonary exercise test
- contraindications to exercise testing according to the American Thoracic Society and American College of Chest Physicians Exercise Testing Guidelines
- cerebral or bone metastasis
- a history of significant cardiovascular disease, hypertension, diabetes or musculoskeletal concerns that might limit their ability to perform active exercises
- severe psychiatric illness compromising adherence to the rehabilitation training routine.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Zuteilung: N / A
- Interventionsmodell: Einzelgruppenzuweisung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Telerehabilitation group
Patients with unresectable thoracic neoplasia receiving chemotherapy treatment
|
The intervention was an 8-week home-based telerehabilitation program (three sessions of about 75 minutes per week) using the eChez-Soi telerehabilitation platform. Through a unique software interface, the eChez-Soi allows for the following three technological aspects: 1- continuous data acquisition and recording from commercial biometric sensors; 2- continuous transmission of the collected data via the Internet to the clinician's computer, allowing the clinician to visualize the biomechanical and physiological parameters in real time; and 3- a challenging gaming environment with interactive exercises performed on musical rhythms. In total, 15 supervised sessions and 9 unsupervised sessions were planned for a total of 24 exercise sessions |
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Number of adverse events during the 8-week telerehabilitation program
Zeitfenster: Along the 8-week program
|
Along the 8-week program
|
|
|
Adherence of the participants to the 8-week telerehabilitation program.
Zeitfenster: Along the 8-week program
|
Adherence was defined as the number of sessions done over the prescribed sessions (supervised and unsupervised) and as percentage of time spent within the target heart rate range (intensities) throughout the cardiovascular exercise sessions
|
Along the 8-week program
|
|
Participants satisfaction with the telerehabilitation platform with the Québec User Evaluation of Satisfaction with Assistive Technology questionnaire (QUEST 2.0)
Zeitfenster: At the end of the 8-week telerehabilitation program
|
The satisfaction of the patients was evaluated using a questionnaire adapted from the Québec User Evaluation of Satisfaction with Assistive Technology questionnaire (QUEST 2.0) that calculates both satisfaction scores for technological aspects and services.
It consists of 12 items rated on a scale from 1 to 5 (1: not satisfied at all to 5: very satisfied).
|
At the end of the 8-week telerehabilitation program
|
|
User satisfaction with health services received with the French version of the Health Care Satisfaction Questionnaire
Zeitfenster: At the end of the 8-week telerehabilitation program
|
To assess more specifically the user satisfaction with health services received, we used the French version of the Health Care Satisfaction Questionnaire.
This is a 26-item questionnaire answered on a four-point Likert scale, where ''1'' represents ''not at all satisfied'' and ''4'' represents ''highly satisfied".
The total score is calculated in percentage and can be computed as the mean overall satisfaction divided in three domains: i) relationship with the professional, ii) delivery of services and iii) organization of services.
Higher scores indicate a higher level of satisfaction.
|
At the end of the 8-week telerehabilitation program
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Cardiopulmonary maximal exercise test (CPET)
Zeitfenster: At baseline and following the 8-week program
|
At baseline and following the 8-week program
|
|
|
Constant workrate cycle exercise test at 80% of the maximal capacity of the patient
Zeitfenster: At baseline and following the 8-week program
|
At baseline and following the 8-week program
|
|
|
Isokinetic quadriceps muscle functions
Zeitfenster: At baseline and following the 8-week program
|
Quadriceps muscle function (strength and endurance) was assessed during an isokinetic endurance test performed at a rate of 30 repetitions at 90°/sec of angular velocity (Biodex, system pro 4, Biodex Medical System, 20 Ramsay Road, Shirley, New York )
|
At baseline and following the 8-week program
|
|
Lean body mass
Zeitfenster: At baseline and following the 8-week program
|
Lean body mass (in Kg) were measured by bioelectrical impedance analysis (TBF-300WA Tanita, Arlington Heights, IL, USA)
|
At baseline and following the 8-week program
|
|
Fat body mass
Zeitfenster: At baseline and following the 8-week program
|
Fat body mass (in Kg) were measured by bioelectrical impedance analysis (TBF-300WA Tanita, Arlington Heights, IL, USA)
|
At baseline and following the 8-week program
|
|
Weight
Zeitfenster: At baseline and following the 8-week program
|
Weight (in Kg) of the patient
|
At baseline and following the 8-week program
|
|
Height
Zeitfenster: At baseline and following the 8-week program
|
Height (in meters) of the patient
|
At baseline and following the 8-week program
|
|
Timed up and go test
Zeitfenster: At baseline and following the 8-week program
|
At baseline and following the 8-week program
|
|
|
Timed stairs test
Zeitfenster: At baseline and following the 8-week program
|
At baseline and following the 8-week program
|
|
|
Distance achieved during the 6 minutes walking test
Zeitfenster: At baseline and following the 8-week program
|
At baseline and following the 8-week program
|
|
|
Cancer specific quality of life with the self-reported European Organization for Research and Treatment of Cancer Quality of Life Questionnaire questionnaire
Zeitfenster: At baseline and following the 8-week program
|
The cancer related quality of life was assessed using the self-reported European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-30) including the lung cancer specific questionnaire QLQ-LC13
|
At baseline and following the 8-week program
|
|
Anxiety and depression with the Hospital Anxiety and Depression Scale questionnaire
Zeitfenster: At baseline and following the 8-week program
|
The French Canadian version of the Hospital Anxiety and Depression Scale (HADS) was used to identify patients suffering of anxiety disorders or depression
|
At baseline and following the 8-week program
|
|
Nutritional status with the mini-nutritional assessment
Zeitfenster: At baseline and following the 8-week program
|
At baseline and following the 8-week program
|
Mitarbeiter und Ermittler
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn
Primärer Abschluss (Voraussichtlich)
Studienabschluss (Voraussichtlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Schätzen)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 20994
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .